Clinical Evidence for Targeting NAD Therapeutically
Nicotinamide adenine dinucleotide (NAD) pharmacology is a promising class of treatments for age-related conditions that are likely to have a favorable side effect profile for human use, given the widespread use of the NAD precursor vitamin B3 supplements. However, despite several decades of active i...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/13/9/247 |